초록 ▼

A method of preventing or treating infection by a range of fungal pathogens in an animal or plant or stored plant product comprising administering an effective amount of a sugar acid, in particular mannonic acid, gluconic acid or galacturonic. The sugar acid can be delivered by a biocontrol that can

A method of preventing or treating infection by a range of fungal pathogens in an animal or plant or stored plant product comprising administering an effective amount of a sugar acid, in particular mannonic acid, gluconic acid or galacturonic. The sugar acid can be delivered by a biocontrol that can manufacture the sugar acid. An exemplified biocontrol is Pseudomonas strain AN5, which is characterized by the capacity to convert aldose to sugar acid. Also disclosed are nucleotide sequences from enzymes in the Pseudomonas PQQ enzyme pathway which may be used to transform microorganisms and plants so that they produce sugar acids at levels sufficient to control the growth or viability of pathogens.

대표청구항 ▼

The invention claimed is: 1. An isolated biocontrol agent for the treatment of a fungal infection in a plant or animal, said agent comprising a mutant of Pseudomonas strain AN5 having all of identifying characteristics of Pseudomonas strain AN5 rif (AGAL Accession No. NM 00/09624) including the fo

The invention claimed is: 1. An isolated biocontrol agent for the treatment of a fungal infection in a plant or animal, said agent comprising a mutant of Pseudomonas strain AN5 having all of identifying characteristics of Pseudomonas strain AN5 rif (AGAL Accession No. NM 00/09624) including the following characteristics: (i) it produces more sugar acid per cell than Pseudomonas strain AN5 when cultured in the presence of a carbon source comprising an aldose; (ii) it is capable of colonizing the infection site of a fungal pathogen of a plant; and (iii) by virtue of (i) and (ii), it has increased ability to reduce or prevent the growth of a fungus compared to Pseudomonas strain AN5 as determined in a standard bioassay for growth of the fungus. 2. The biocontrol agent according to claim 1 wherein the sugar acid is selected from the group consisting of mannonic acid, gluconic acid, and galacturonic acid. 3. The biocontrol agent according to claim 2 wherein the sugar acid is gluconic acid. 4. The biocontrol agent according to claim 1 wherein the fungal pathogen is selected from the group consisting of: Alternaria spp.; Armillaria mellae; Arthrobotrys oligosporus; Boletus granulatus; Botrytis fabae; Botritis cinerea; Candida albicans; Claviceps purpurea; Cronartium ribicola; Epicoccum purpurescens; Epidermophyton floccosum; Fomes annosus; Fusarium oxysporum; Gaeumannomyces graminis var. tritici; Glomerella cingulata; Gymnosporangium juniperi- virginianae; Microsporum canis; Monilinia fructicola; Physoderma alfalfae; Phytopthera infestans; Pityrosporum orbiculare (Malassezia furfur); Polyporus sulphureus; Puccinia spp.; Saccharomyces cerevisiae; Septoria apiicola; Trichophyton rubrum; T. mentagrophytes; Ustilago spp.; Venturia inaequalis; and Verticillium dahliae. 5. The biocontrol agent according to claim 4 wherein the fungal pathogen is G. graminis (take-all fungus). 6. The biocontrol agent according to claim 4 wherein the fungal pathogen is Botrytis fabae. 7. A method of treatment of a fungal infection in a plant comprising applying the biocontrol agent of claim 1 to the plant under conditions sufficient for the biocontrol agent to produce an anti-fungal effective amount of a sugar acid sufficient to prevent growth of a fungal pathogen of the plant. 8. The method according to claim 7 wherein the fungal pathogen is selected from the group consisting of: Alternaria spp.; Armillaria mellae; Arthrobotrys oligosporus; Boletus granulatus; Botrytis fabae; Botritis cinerea; Candida albicans; Claviceps purpurea; Cronartium ribicola; Epicoccum purpurescens; Epidermophyton floccosum; Fomes annosus; Fusarium oxysporum; Gaeumannomyces graminis var. tritici; Glomerella cingulata; Gymnosporangium juniperi- virginianae; Microsporum canis; Monilinia fructicola; Physoderma alfalfae; Phytopthera infestans; Pityrosporum orbiculare (Malassezia furfur); Polyporus sulphureus; Puccinia spp.; Saccharomyces cerevisiae; Septoria apiicola; Trichophyton rubrum; T. mentagrophytes; Ustilago spp.; Venturia inaequalis; and Verticillium dahliae. 9. The method according to claim 8 wherein the fungal pathogen is G. graminis (take-all fungus). 10. The method according to claim 8 wherein the fungal pathogen is Botrytis fabae. 11. The method according to claim 7 wherein the sugar acid is selected from the group consisting of mannonic acid, gluconic acid, and galacturonic acid. 12. The method according to claim 11 wherein the sugar acid is gluconic acid. 13. The method of claim 7 wherein the biocontrol agent comprises mutant Pseudomonas strain AN5rif (AGAL Accession No. NM 00/09624). 14. A method of increasing the post-harvest storage of a product from a non-aquatic plant comprising applying to said product the biocontrol agent according to claim 1 under conditions sufficient for the biocontrol agent to produce an anti-fungal effective amount of a sugar acid sufficient to prevent growth of a fungal pathogen on said product. 15. The method according to claim 14 wherein the fungal pathogen is selected from the group consisting of: Alternaria spp.; Armillaria mellae; Arthrobotrys oligosporus; Boletus granulatus; Botrytis fabae; Botritis cinerea; Candida albicans; Claviceps purpurea; Cronartium ribicola; Epicoccum purpurescens; Epidermophyton floccosum; Fomes annosus; Fusarium oxysporum; Gaeumannomyces graminis var. tritici; Glomerella cingulata; Gymnosporangium juniperi- virginianae; Microsporum canis; Monilinia fructicola; Physoderma alfalfae; Phytopthera infestans; Pityrosporum orbiculare (Malassezia furfur); Polyporus sulphureus; Puccinia spp.; Saccharomyces cerevisiae; Septoria apiicola; Trichophyton rubrum; T. mentagrophytes; Ustilago spp.; Venturia inaequalis; and Verticillium dahliae. 16. The method according to claim 15 wherein the fungal pathogen is G. graminis (take-all fungus). 17. The method according to claim 15 wherein the fungal pathogen is Botrytis fabae. 18. The method according to claim 14 wherein the sugar acid is selected from the group consisting of mannonic acid, gluconic acid, and galacturonic acid. 19. The method according to claim 18 wherein the sugar acid is gluconic acid. 20. The method of claim 14 wherein the biocontrol agent comprises mutant Pseudomonas strain AN5rif (AGAL Accession No. NM 00/09624). 21. A phytoprotective composition for the treatment of a fungal infection of a plant comprising the biocontrol agent according to claim 1 in combination with a phytopathologically-acceptable diluent or wetting agent. 22. The biocontrol agent according to claim 1 wherein the mutant of Pseudomonas strain AN5 is a naturally-occurring mutant having antibiotic resistance. 23. The biocontrol agent of claim 22 wherein the antibiotic resistance confers on the mutant an ability to grow on rifampicin. 24. The method of claim 7 wherein the biocontrol agent comprises a naturally-occurring mutant of Pseudomonas strain AN5 having antibiotic resistance. 25. The method of claim 24 wherein the antibiotic resistance confers on the mutant an ability to grow on rifampicin. 26. The method of claim 14 wherein the biocontrol agent comprises a naturally-occurring mutant of Pseudomonas strain AN5 having antibiotic resistance. 27. The method of claim 26 wherein the antibiotic resistance confers on the mutant an ability to grow on rifampicin.